Literature DB >> 3574697

Flunarizine- and cinnarizine-induced extrapyramidal reactions.

F Micheli, M F Pardal, M Gatto, M Torres, G Paradiso, I C Parera, R Giannaula.   

Abstract

Cinnarizine and flunarizine are selective calcium blockers that have been used to treat and prevent vertigo. We studied 15 patients who had extrapyramidal syndromes after taking these drugs. Eleven patients had parkinsonism, one with persistent akathisia as well; one had an orofacial tremor; one, acute akathisia alone; and one an acute dystonic reaction. All but one improved when the drug therapy was discontinued. Seven patients were also depressed during treatment. Cinnarizine and flunarizine must therefore be added to the list of potentially risky drugs known to induce extrapyramidal reactions and depression.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3574697     DOI: 10.1212/wnl.37.5.881

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  19 in total

1.  Lichenoid eruption associated with cinnarizine use.

Authors:  María Ramallal; Miguel Gallego; Teresa Bermejo; Benito García
Journal:  Pharm World Sci       Date:  2002-12

Review 2.  Essential tremor.

Authors:  Joaquim Jos Ferreira; Cristina Sampaio
Journal:  BMJ Clin Evid       Date:  2007-05-01

3.  A postmarketing study of flunarizine in migraine and vertigo.

Authors:  G H de Bock; J Eelhart; H W van Marwijk; T P Tromp; M P Springer
Journal:  Pharm World Sci       Date:  1997-12

4.  Aggravation of Parkinson's disease by cinnarizine.

Authors:  M Fernandez Pardal; J Fernandez Pardal; F Micheli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-01       Impact factor: 10.154

5.  Risk of parkinsonism induced by flunarizine or cinnarizine: a population-based study.

Authors:  Hsiu-Li Lin; Hsiu-Chen Lin; Yuan-Fu Tseng; Shih-Chang Chen; Chien-Yeh Hsu
Journal:  Eur J Clin Pharmacol       Date:  2016-12-16       Impact factor: 2.953

6.  Drug-induced tremor of the tongue.

Authors:  A S Gabellini; P Martinelli; G Coccagna
Journal:  Ital J Neurol Sci       Date:  1989-02

Review 7.  Diagnosis and treatment of Parkinson's disease in the elderly.

Authors:  J I Sage; M H Mark
Journal:  J Gen Intern Med       Date:  1994-10       Impact factor: 5.128

8.  Antiparkinsonian Agents : Clinically Significant Drug Interactions and Adverse Effects, and Their Management.

Authors:  A Dalvi; B Ford
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

9.  Flunarizine increases PRL secretion in normal and in migraineous women.

Authors:  U Bonuccelli; P Piccini; A M Paoletti; A Nuti; A Colzi; G B Melis; A Muratorio
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

10.  [Drug treatment as migraine prophylaxis.].

Authors:  H C Diener; A Ziegler
Journal:  Schmerz       Date:  1989-12       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.